GeneDx Holdings Corp.WGSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank40
3Y CAGR-8.6%
5Y CAGR-0.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-8.6%/yr
Annual compound
5Y CAGR
-0.6%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$105.00M+23.2%
2024$85.21M-14.5%
2023$99.68M-27.5%
2022$137.40M-65.7%
2021$400.57M+270.4%
2020$108.13M-